In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Angiopoietin-2 in Cerebrospinal Fluid and Serum as a Predictive Biomarker for Brain Injury.

    Final Number:
    420

    Authors:
    Prashant Chittiboina MD, MPH; Vijay Ganta; Keith L Soctt MD; Walter E Cromer PhD; Michael J Mathis MA; Anil Nanda MD FACS; Steven J Alexander PhD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2012 Annual Meeting

    Introduction: As roles of angiopoietins in brain injury become better understood, clinical uses for Ang-2 as a vascular stress biomarker are increasingly being explored. Several studies have established serum Ang-2 as a marker of systemic illness severity, reflecting vascular injury. Less is known about how angiopoietins, e.g. pro-inflammatory Ang-2, change in other compartments in brain injury. Since Ang-2 is stable for 24 h and resists freeze-thaw cycles it may represent a reliable and durable clinical marker for brain vascular injury.

    Methods: We compared Ang-2 in cerebrospinal fluid (CSF) collected from clinically defined subarachnoid hemorrhage (SAH, n=7) vs. controls (n=4) by immunoblotting.

    Results: We found a large (2.66-fold) and significant (p=0.043) increase in Ang-2 (range = 8-370% of control). We also evaluated Ang-2 in serum from mice undergoing middle cerebral artery occlusion for 2h / 24 hours reperfusion, (‘I/R’). We observed a significant decrease (p=0.001) in serum Ang-2 levels after I/R. Despite differences in mouse and human samples, these results suggest contrasting changes in serum and CSF Ang-2, with ischemic injury decreasing serum Ang-2 with a concomitant increase in CSF Ang-2.

    Conclusions: The results suggests that serum/CSF Ang-2 ratios may be a useful biomarker of vascular stress and temporal changes in serum/CSF ratios may predict disease severity and prognosis. Further experiments to confirm serum Ang-2 in SAH and traumatic brain injury TBI are underway to validate these markers in SAH/TBI.

    Patient Care: The results from our study may help develop predictive tests like 2D gel electrophoresis/MALDI-TOF protein identification of CSF biomarkers that may correlate closely with disease outcomes. The lessons learnt may help establish close correlation of outcome, survival, age, blood gases with Ang-1/Ang-2 levels in the acute phase after brain injury like trauma and subarachnoid hemorrhage.

    Learning Objectives: To identify changes in CSF biomarkers (e.g. angiopoietins/ Ang-1/Ang-2 ratios) that may provide novel clinical indicators both of disease severity and mechanism. to identify changes in the ratios of Angiopoietin-1 and -2 as well as their absolute levels that may represent important targets of therapy in brain injury.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy